This drug takes the first new approach to schizophrenia treatment in decades," Farchione continued. "This approval offers a ...
Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This ...
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...
The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...
Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
Cobenfy was approved to reduce the psychotic symptoms associated with schizophrenia. It is a new type of medicine that works ...
Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...
The U.S. FDA issued warnings for ANSWERS Pet Food and Darwin's Natural Pet Products as they contain Salmonella and Listeria.
Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the ...
Shares in Bristol-Myers Squibb (BMY) surged Friday, after the Food and Drug Administration approved the drugmaker's novel ...